Furthermore, in agreement with the known ability of hyperactive YAP/TAZ to augment cell proliferation, LATS1 silencing in human luminal breast cancer-derived cells yielded a transcriptional signature strongly enriched for cell cycle and mitosis-related pathways (Fig S6H). This evidence concerns the gene LATS1 and breast carcinoma.